INCYTE CORP

Nasdaq:INCY

Services-Commercial Physical & Biological Research·WILMINGTON, DE

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/10/26	→
10-Q	Q3 2025	9/30/25	10/28/25	→
10-Q	Q2 2025	6/30/25	7/29/25	→
10-Q	Q1 2025	3/31/25	4/29/25	→
10-K	FY 2024	12/31/24	2/10/25	→
10-Q	Q3 2024	9/30/24	10/29/24	→
↓

Earnings Releases (8-K)

31 shown

Filed	Period
2/10/26	Q1 FY2026	→
10/28/25	Q3 FY2025	→
7/29/25	Q2 FY2025	→
4/29/25	Q1 FY2025	→
2/10/25	Q1 FY2025	→
10/29/24	Q3 FY2024	→
↓

News (8-K)

33 shown

Filed	Type	Description
3/6/26	Other	Other Events	→
12/12/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
8/7/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/27/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/11/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

15 shown

Filed	Form	Description
7/2/25	S-8	S-8	→
6/18/25	S-8	S-8	→
6/18/25	S-8	S-8	→
4/29/25	ARS	ARS	→
2/10/25	S-3ASR	S-3ASR	→
4/29/24	ARS	ARS	→
↓

Filing History(1001 filings)

TypeDateAccessionPeriodSize

8-K

Mar 6, 2026

0000879169-26-0000138-K

Feb 27, 2026

132.9 KB

Feb 23, 2026

0001205703-26-000006FORM 4

Feb 19, 2026

11.9 KB

144

Feb 19, 2026

0001950047-26-001500

—

4.9 KB

SCHEDULE 13D/A

Feb 10, 2026

0001104659-26-012814

—

27.3 KB

10-K

Feb 10, 2026

0000879169-26-00001010-K

Dec 31, 2025

12.7 MB

8-K

Feb 10, 2026

0000879169-26-0000068-K

Feb 10, 2026

541.8 KB

144

Feb 9, 2026

0001950047-26-001066

—

8.2 KB

Feb 4, 2026

0001780915-26-000006FORM 4

Feb 2, 2026

5.2 KB

Feb 4, 2026

0002039219-26-000004FORM 4

Feb 2, 2026

5.1 KB

Jan 21, 2026

0002039219-26-000002FORM 4

Jan 16, 2026

5.1 KB

Jan 21, 2026

0001205703-26-000002FORM 4

Jan 16, 2026

5.5 KB

Jan 21, 2026

0001673776-26-000006FORM 4

Jan 16, 2026

5.5 KB

Jan 21, 2026

0002050035-26-000004FORM 4

Jan 16, 2026

5.5 KB

Jan 21, 2026

0002015975-26-000002FORM 4

Jan 16, 2026

5.5 KB

Jan 21, 2026

0001912317-26-000002FORM 4

Jan 16, 2026

5.5 KB

Jan 21, 2026

0002079962-26-000002FORM 4

Jan 16, 2026

5.5 KB

Jan 21, 2026

0001780915-26-000004FORM 4

Jan 16, 2026

6.8 KB

Jan 8, 2026

0002050035-26-000002FORM 4

Jan 6, 2026

6.4 KB

Jan 7, 2026

0001673776-26-000004FORM 4

Jan 5, 2026

4.9 KB

144

Jan 7, 2026

0001950047-26-000223

—

4.9 KB

144

Jan 6, 2026

0001950047-26-000172

—

7.5 KB

144

Jan 5, 2026

0001950047-26-000107

—

6.8 KB

Jan 5, 2026

0001409601-26-000002FORM 4

Dec 31, 2025

5.2 KB

144

Jan 5, 2026

0001950047-26-000096

—

6.9 KB

Jan 5, 2026

0001177917-26-000002FORM 4

Dec 31, 2025

5.2 KB

25 filings shown

INCYTE CORP

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1001 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→
5/30/24	DEFA14A	DEFA14A	→
4/29/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
6/7/23	DEFA14A	DEFA14A	→
↓

Filed	Form	Description
2/23/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
1/21/26	4	4	→
1/21/26	4	4	→
1/21/26	4	4	→
↓

Filed	Form	Description
2/19/26	144	144	→
2/10/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/9/26	144	144	→
1/7/26	144	144	→
1/6/26	144	144	→
1/5/26	144	144	→
↓